Regulatory

Regulatory  ·  Weekly Digest 22 Feb to 28 Feb 2025
Pyxis Oncology granted FDA Fast Track Designation for PYX-201 monotherapy in patients with recurrent or metastatic head and neck cancer

Weekly Digest – February 2025 Weekly Digest – February 2025 26 Feb 2025: Pyxis Oncology granted FDA fast track designation for PYX-201 monotherapy in patients with recurrent or metastatic head and neck cancer The FDA has granted Fast Track Designation […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 22 Feb to 28 Feb 2025
Hansoh Pharma’s HS-20093 receives Breakthrough Therapy Designation from NMPA for Osteosarcoma

Weekly Digest – February 2025 Weekly Digest – February 2025 25 Feb 2025: Hansoh Pharma’s HS-20093 receives Breakthrough Therapy Designation from NMPA for Osteosarcoma Hansoh Pharma’s B7-H3-targeted ADC, HS-20093, has been granted Breakthrough Therapy Designated Drug status by China’s NMPA […]

by Sandhya Ramalingam

Continue Reading